Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
FAQs Use this text to answer questions in as much detail as possible for your customers
About the Phase 2 EMBRAZE Trial in Obesity EMBRAZE was a randomized, double-blind, placebo-controlled, Phase 2 proof-of-concept trial evaluating the efficacy, safety and pharmacokinetics of apitegromab at 10mg/kg in adults with a body mass index (BMI) of 27.0 kg/m 2 (overweight) with at least one weight-related comorbid condition or a BMI of 30.0 kg/m 2 (obese) while receiving tirzepatide
Topical and nutricosmetic products for healthy hair and dermal antiaging using "dual-acting" (2 for 1) plant-based peptides, hormones, and cannabinoids
It could be raw veggies, a salad, fried or greasy foods
US$ 26.33
US$ 29.08
US$ 23.93
US$ 29.71
US$ 21.27
US$ 27.22
